Hmm. So do you mean it’s not data that is new to the company in as much as it is the data from the most recent trial, or do you mean it’s not new data as in it has been released publicly previously? I’d certainly agree it’s the data which pertains to the most recent trials and to that extent it’s not “new”. However I’d also say that given the data of that trial has not yet been release publicly then when that information is presented at the upcoming conference that will be the first release of the data publicly (unless of course released otherwise between now and the conference).
Thus, I’m sure you are not intending to downramp but I’m not convinced you are speaking from a position of understanding of what has thus far been released and what is awaiting release - unless you can point out where the actual data from that most recent trial has been released?
BIT Price at posting:
21.5¢ Sentiment: Buy Disclosure: Held
